The Global Mammography Market was valued at US$ 1,823.1 Mn in 2020 is expected to reach US$ 3,417.0 Mn by 2027, with a growing CAGR of 9.4% during the forecast period (2021-2027).
Mammography (also called mastography) is a process in which low-energy X-rays (usually about 30 kVp) are used to examine human breasts for screening and diagnosis. The aim of mammography is to detect breast cancer at early stage, usually by detecting typical masses or micro calcifications. In 2020, breast cancer is the most prevalent type of cancer, with a dominance rate of 11.7%.
The primary factors driving the growth of the mammography market include the increasing prevalence of breast cancer, investment by various organizations in breast cancer screening activities, and technological advances in the field of breast imaging.
According to a 2018 report from the Canters for Disease Control and Prevention (CDCP), regardless of race or ethnicity, breast cancer is one of the most common cancers in women. It is also the third most common cause of cancer deaths among American Indian/Alaska native women.
Supportive government initiatives to enhance clinical interpretation and improve the access to breast cancer screening systems are one of the key factors that are expected to drive demand for mammography during the forecast period. The Health Resources and Services Administration (HRSA) has introduced the Federal Comprehensive Health Center program to increase screening procedures in under developed regions. However, during the forecast period, the adverse effects of radiation exposure and the risks associated with mammography are expected to hinder the market growth.
The Global Mammography Industry Segmentation:
By Product Type
By Technology
By Region
Based on product, digital systems held the largest share in 2020.
Based on product, the mammography market has been segmented into digital systems, film screen systems, biopsy systems, analog systems, and 3D systems. The maximum share held by the digital systems segment in the global market can be attributed to rising demand for technologically advanced breast cancer screening and diagnostic equipment. Also, favourable reimbursement policies and increasing government support for improving screening results are some of the key factors driving the global mammography market.
3D Systems segment is expected to witness the fastest growth during the forecast period. The promulgation of the (Medical Imaging Modernization Act) in 2015 is one of the key factors driving the surge in demand for 3D systems in the next few years. The growing demand for highly specific screening equipment to reduce return visits, false positives, and missed cancer diagnosis is also one of the main factors leading to the surge in demand.
Based on technology, digital technology segment accounted for the largest share of the market.
The global mammography market is segmented into CAD technology, breast tomosynthesis, and digital technology. In 2020, digital technology segment accounted for the largest share of the market. Rapidly changing technology is one of the key factors attributing to the augmented adoption and utilization of digital mammography equipment. Advances in hybrid imaging technologies for mammography, such as CAD for mammography, and growing product approvals in this market segment, are some of the attributes that are responsible for the largest market share.
However, breast tomosynthesis is anticipated to propel the market with the highest growth during the forecast period. This technology was first introduced in Europe by Hologic, Inc. in 2008. The product was approved for sale in the US market in 2011. The growing demand for advanced technologies with improved cancer detection and diagnostic sensitivity is one of the key attributes representing potential market growth during the forecast period.
Geographically, North America accounted for the largest share of the global mammography industry.
North America accounted for the largest share of the mammography market in 2020 and is expected to maintain its dominance during the forecast period. North America’s advanced healthcare facilities, and reimbursement scenario responsible for the largest share in the market. In addition, it is expected that the upsurge in the number of mammography equipment in US hospitals and diagnostic centers coupled with the number of equipment per million female population will also drive market growth.
Asia pacific is expected to grow at the fastest rate during the forecast period from 2021 to 2027. Emerging economies in the region, such as India and China, are lucrative markets owing to the dynamic changes in the lifestyles of some cities in these countries have led to a high prevalence of breast cancer. The local presence of important players such as Hologic, Fujifilm, and Philips Healthcare is one of the key factors that will further promote market development in the next few years.
Company Profiles and Competitive Intelligence
The key players operating in the market are:
The report also provides in-depth analysis of Mammography market dynamics such as drivers, and restraints.
Drivers
Restraints
COVID-19 Impact on the Mammography Market
The COVID-19 pandemic has been changing the growth of various markets, and the direct impact of the epidemic varies. Although demand in some industries has declined, many markets may continue to be intact and show promising growth opportunities. Initially, the outbreak of COVID-19 had a strong impact on the mammography market, as hospitals and healthcare services were significantly reduced due to social distancing measures taken by governments around the world. In addition, the COVID-19 pandemic has not only affected the global economy, but also has a huge impact on the operation of general hospital care for non-COVID-19 patients in hospitals around the world. As many hospitals and screening centers are closed due to lockdown, it is projected that the demand for mammography will be suppressed for the short term.
The report also provides in-depth analysis of key trends in Mammography market
| Sr. No. | Trends | Impact |
| 1 | Breakthrough of COVID 19 decreased certain healthcare services owing to social distancing measures implemented by governments globally | Negative |
| 2 | Several hospitals and screening centers remain closed due to lockdown | Negative |
The report also provides in-depth analysis of recent news developments and investments
The unique insights provided by this report also includes the following:
Ask for free product review call with the author
Share your specific research requirements for a customized report
Request for due diligence and consumer centric studies
Request for study updates, segment specific and country level reports
Log in / Register
